Clinical Trial Update: Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fucoidan to prevent chemotherapy-related fatigue in patients with gastrointestinal or gynecologic cancers; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer
• Gynecologic Cancer

Drugs mentioned

• Fucoidan (fucoidan)

Snippet

Sponsor: Mayo Clinic | Conditions: Malignant Digestive System Neoplasm, Malignant Female Reproductive System Neoplasm | Phase 2 | Status: RECRUITING